Early Access — free while we kick the tires
EdgarHawk

HighCape Capital, L.P.

Director

Director 10% Owner
2 filings analyzed · 1 company · Latest 2025-03-13

Companies

Company Buys Sells Direction
ELUTIA INC. ELUT 2 0 Net buying

Activity

March 2025
2025-03-13 ELUTIA INC. ELUT
medium
Buy
420,000 shares
$1,050,000
Significance 4/10

HighCape Capital director bought 420,000 shares of ELUT at $2.50 on 2025-02-03 for $1,050,000.00

HighCape Capital, L.P., a director, purchased 420,000 shares at $2.50, increasing holdings by 4.6% to 9,520,232 shares. The stock currently trades at $3.25, up 30% over 30 days but down 21.5% over 90 days and 34.5% from its 52-week high of $4.96. The company is small-cap at $2.1M market capitalization with quarterly revenue of $5.9M and recent net income of $1.3M, though it was unprofitable over its most recent full fiscal year with annual revenue declining 1.5% year-over-year. The insider's cross-ticker track record shows 1 prior buy with a 30-day average return of +12.4%, but this is the only measurable same-ticker trade, limiting pattern evidence at this specific company.

2025-03-13 ELUTIA INC. ELUT
medium
Buy
420,000 shares
$1,050,000
Significance 5/10

Director HighCape Capital bought 420,000 shares of ELUT at $2.50; post-transaction holdings 9,520,232 shares (+4.6%)

HighCape Capital, a director, purchased 420,000 shares at $2.50 on 2025-02-03, increasing holdings to 9,520,232 shares. The stock has since appreciated 22.2% over 30 days but remains 34.5% below its 52-week high and 21.5% lower over 90 days, placing the purchase within a volatile trading range. Fundamentals show the company generated $5.9M in quarterly revenue with $1.3M net income, but full-year net income was negative with annual revenue declining 1.5%, and the $2.1M market cap reflects a small-cap profile. The insider's cross-ticker track record shows a single prior buy averaging +12.4% return at 30 days, though no measurable 90-day outcomes yet exist at this ticker to assess pattern consistency.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access